These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 954483)

  • 1. Distribution of sulfonamides and sulfonamide potentiators between red blood cells, proteins and aqueous phases of the blood of different species.
    Berneis K; Boguth W
    Chemotherapy; 1976; 22(6):390-409. PubMed ID: 954483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrophobic bonding of sulfonamide drugs with serum albumin.
    Fujita T
    J Med Chem; 1972 Oct; 15(10):1049-56. PubMed ID: 4672194
    [No Abstract]   [Full Text] [Related]  

  • 3. Effective plasma and urine concentration of some sulfonamides and sulfonamide combinations.
    Tuomisto J; Saris NE
    Ann Med Exp Biol Fenn; 1970; 48(1):38-48. PubMed ID: 5419724
    [No Abstract]   [Full Text] [Related]  

  • 4. [Demonstration of two trimethoprim/sulfonamide combinations in bronchoalveolar lavage fluid of horses and determination of blood levels].
    Fey K; Klatt P; Schmidt H; Sasse HH
    Tierarztl Prax; 1995 Feb; 23(1):59-65. PubMed ID: 7792777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Binding of some sulfanilamides to blood proteins of man. 1. Determinations of low sulfanilamide concentrations in vitro at room temperature].
    Spring P
    Arzneimittelforschung; 1966 Mar; 16(3):346-54. PubMed ID: 6013844
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-protein binding. IV. Modulation of binding. Increasing activity of sulfonamides with displacing agents: a review.
    Anton AH
    Ann N Y Acad Sci; 1973 Nov; 226():273-92. PubMed ID: 4588442
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative determination of the bacteriostatically active fraction of sulfonamides and the sum of their inactive metabolites in the body fluids.
    Rieder J
    Chemotherapy; 1972; 17(1):1-21. PubMed ID: 5009465
    [No Abstract]   [Full Text] [Related]  

  • 8. Binding of sulfonamides to erythrocyte proteins and possible drug-drug interaction.
    Matsumoto K; Miyazaki H; Fujii T; Amejima H; Furukawa H; Hashimoto M
    Chem Pharm Bull (Tokyo); 1989 Oct; 37(10):2807-10. PubMed ID: 2611942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Displacement of albumin-bound antimicrobial agents by bilirubin.
    Bratlid D; Bergan T
    Pharmacology; 1976; 14(5):464-72. PubMed ID: 1031216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of sulfadimethoxine, sulfamethoxazole, trimethoprim and their main metabolites in porcine plasma by column switching HPLC.
    Mengelers MJ; Oorsprong MB; Kuiper HA; Aerts MM; van Gogh ER; van Miert AS
    J Pharm Biomed Anal; 1989; 7(12):1765-76. PubMed ID: 2490565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saturable binding of indisulam to plasma proteins and distribution to human erythrocytes.
    Zandvliet AS; Copalu W; Schellens JH; Beijnen JH; Huitema AD
    Drug Metab Dispos; 2006 Jun; 34(6):1041-6. PubMed ID: 16565173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BINDING CAPABILITY OF VARIOUS SULFONAMIDES TO SERUMS OF DIFFERENT ANIMAL SPECIES.
    GENAZZANI E; PAGNINI G
    Am J Vet Res; 1963 Nov; 24():1212-6. PubMed ID: 14081457
    [No Abstract]   [Full Text] [Related]  

  • 13. Prediction of drug-drug interaction from in vitro plasma protein binding and metabolism. A study of tolbutamide-sulfonamide interaction in rats.
    Sugita O; Sawada Y; Sugiyama Y; Iga T; Hanano M
    Biochem Pharmacol; 1981 Dec; 30(24):3347-54. PubMed ID: 7326045
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological implications of molecular and crystal structures of sulfadimethoxine, sulfadoxine, and sulfisoxazole.
    Shefter E; Chmielewicz ZF; Blount JF; Brennan TF; Sackman BF; Sackman P
    J Pharm Sci; 1972 Jun; 61(6):872-7. PubMed ID: 4558258
    [No Abstract]   [Full Text] [Related]  

  • 15. Circular dichroic investigations into binding of sulfonamides to serum albumin.
    Otagiri M; Nakamura H; Imamura Y; Matsumoto U
    Pharm Weekbl Sci; 1989 Dec; 11(6):207-12. PubMed ID: 2616252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological properties of 4-sulfanilamido-3,6-dimethoxypyridazine (CS-61)--a new sulfonamide.
    Seki T; Segawa T; Komatsu T; Nakagome T
    Arzneimittelforschung; 1965 Dec; 15(12):1441-5. PubMed ID: 4960234
    [No Abstract]   [Full Text] [Related]  

  • 17. Binding of four sulphonamides to human albumin.
    Zini R; d'Athis P; Hoareau A; Tillement JP
    Eur J Clin Pharmacol; 1976 Jun; 10(2):139-45. PubMed ID: 964290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Physicochemical and biological studies on sulfonamides. 2. Protein-binding, pharmacokinetics and distribution of 5 sulfonamides in rabbits].
    RIEDER J
    Arzneimittelforschung; 1963 Feb; 13():89-95. PubMed ID: 13982262
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of disease, drugs, and dilution on the binding of sulfonamides in human plasma.
    Anton AH
    Clin Pharmacol Ther; 1968; 9(5):561-7. PubMed ID: 5676798
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma levels of trimethoprim and sulfonamide after administration of trimethoprim-sulfamethoxazole and trimethoprim-sulfamoxole.
    Gupta KC; Desai NK; Paul T; Sheth UK
    Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(12):536-7. PubMed ID: 7228448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.